Skip to main content
Log in

Validity Assessment for the Results of Three Inflammatory Markers in Exhaled Breath Condensate: A Pilot Study

  • Original
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

This study was initiated to assess the validity of eicosanoid determination in exhaled breath condensate by immunoassays. The results were compared to those obtained from liquid chromatographic methods with mass spectrometric detection and with the theoretical spiked amount of condensate. Therefore, spiked exhaled breath condensate was prepared achieving samples for comparison of identical aliquots. The three most often analysed inflammatory markers in the literature, i.e. leukotriene B4, prostaglandin E2, and 8-isoprostane-prostaglandin F were selected for comparison. Three concentrations of spiked and non-spiked breath condensate matrix were examined. There was an up to 800% overestimation of the eicosanoid quantities revealed by the immunoassay kits used in this study compared to the liquid chromatographic method with mass spectrometric detection which was in line with the nominal amount spiked. Full validation of immunoassay for the determination of inflammatory markers should be performed before further interpretations and consequences will be taken from the absolute values quantified by enzyme-immunoassays. For improving the accuracy of enzyme linked immunoassay (ELISA) results a collaborative work applying ELISA and LC–MS–MS should be performed in order to spotlight the advantages of the ELISA-method.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Gessner C, Kuhn H, Seyfarth HJ, Pankau H, Winkler J, Schauer J, Wirtz H (2001) Pneumologie 55:414

    Article  CAS  Google Scholar 

  2. Phillips M, Gleeson K, Hughes JMB, Greenberg J, Cataneo RN, Baker L, McVay MP (1999) Lancet 353:1930

    Article  CAS  Google Scholar 

  3. Hanazawa T, Kharitonov SA, Barnes PJ (2000) Am J Respir Crit Care Med 162:1273–1276

    CAS  Google Scholar 

  4. Baraldi E, Carraro S, Alinovi R, Pesci A, Ghiro L, Bodini A, Piacentini G, Zacchello F, Zanconato S (2003) Thorax 58:505–509

    Article  CAS  Google Scholar 

  5. Biernacki WA, Kharitonov SA, Barnes PJ (2003) Thorax 58:294–298

    Article  CAS  Google Scholar 

  6. Kharitonov S, Barnes P (2001) Am J Respir Crit Care Med 163:1693–1722

    CAS  Google Scholar 

  7. Barnes PJ, Chung KF, Page CP (1998) Pharmacol Rev 50:515–596

    CAS  Google Scholar 

  8. Carpagnano GE, Barnes PJ, Geddes DM, Hodson ME, Kharitonov SA (2003) Am J Respir Crit Care Med 167:1109–1112

    Article  Google Scholar 

  9. Repine JE, Bast A, Lankhorst I (1997) Am J Respir Crit Care Med 156:341–357

    CAS  Google Scholar 

  10. Czebe K, Barta I, Antus B, Valyon M, Horvath I, Kullmann T (2008) Respir Med 102:720–725

    Article  Google Scholar 

  11. Conventz A, Musiol A, Brodowsky C, Müller-Lux A, Dewes P, Kraus T, Schettgen T (2007) J Chromatogr B 860:78–85

    Article  CAS  Google Scholar 

  12. Montuschi P, Martello S, Felli M, Mondino C, Chiarotti M (2004) Rapid Commun Mass Spectrom 18:2723–2729

    Article  CAS  Google Scholar 

  13. Carpenter CT, Price PV, Christman BW (1998) Chest 114:1653–1659

    Article  CAS  Google Scholar 

  14. Hyde RW (2002) Am J Respir Crit Care Med 165:561–562

    Google Scholar 

  15. Gonzalez-Reche LM, Musiol AK, Muller-Lux A, Kraus T, Goen T (2006) J Occup Med Toxicol 1:5

    Article  Google Scholar 

  16. Montuschi P, Ragazzoni E, Valente S, Corbo G, Mondino C, Ciappi G, Ciabattoni G (2003) Inflamm Res 52:502–507

    Article  CAS  Google Scholar 

  17. Effros RM, Su J, Casaburi R, Shaker R, Biller J, Dunning M (2005) Curr Opin Pulm Med 11:135–139

    Article  Google Scholar 

  18. Horváth I, Hunt J, Barnes P, Alving K, Antczak A, Baraldi E, Becher G, Beurden Mv, Corradi M, Dekhuijzen R, Dweik R, Dwyer T, Effros R, Erzurum S, Gaston B, Gessner C, Greening A, Ho L, Hohlfeld J, Jöbsis Q, Laskowski D, Loukides S, Marlin D, Montuschi P, Olin A, Redington A, Reinhold P, Rensen Ev, Rubinstein I, Silkoff P, Toren K, Vass G, Vogelberg C, Wirtz H (2005) ATS/ERS task force on exhaled breath condensate. Eur Respir J 26:523–548

    Article  Google Scholar 

Download references

Acknowledgments

The authors want to thank Mrs. Musiol and Mrs. Dewes for the support organizing this study and Mrs. Decker for her technical assistance for the ELISA technique. Special thanks to Kathy Bischof for her editorial assistance. Furthermore, the authors would like to thank Dr. Thomas Schettgen for preparing the revision of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thomas Kraus.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gonzalez-Reche, L.M., Schaefer, D., Göen, T. et al. Validity Assessment for the Results of Three Inflammatory Markers in Exhaled Breath Condensate: A Pilot Study. Chroma 70, 1387–1392 (2009). https://doi.org/10.1365/s10337-009-1313-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1365/s10337-009-1313-7

Keywords

Navigation